Crossmark

Maximum doses of renin-angiotensin axis blockers in diabetic nephropathy?

Crossref DOI link: https://doi.org/10.1016/j.medcle.2021.01.008

Published Print: 2021-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Robles Pérez-Monteoliva, Nicolás Roberto

Arévalo Lorido, José Carlos
License Information

Text and Data Mining valid from 2021-07-01

stm-asf valid from 2021-07-01

stm-asf valid from 2021-07-01

stm-asf valid from 2021-07-01

stm-asf valid from 2021-07-01

stm-asf valid from 2021-07-01
More Information

This article is maintained by: Elsevier

Article Title: Maximum doses of renin-angiotensin axis blockers in diabetic nephropathy?

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2021.01.008

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2021.01.007

Content Type: article

Copyright: © 2021 Elsevier España, S.L.U. All rights reserved.